Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions

Overview of attention for article published in Frontiers in oncology, August 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

TARGETED CYTOKINE CONSTRUCT FOR ENGINEERED CELL THERAPY

Application WO-2022125711-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.